# OnCo record apact (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/apact/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "apact", "NCT01964430" ;
  schema:name "APACT"@en ;
  schema:alternateName "ABI-007-PANC-003"@en ;
  schema:description "APACT tested whether adding nab-paclitaxel to gemcitabine after pancreatic surgery delays relapse; by the independent radiologists' reading it did not (19.4 against 18.8 months), although patients on the combination lived about four months longer at five years, so the regimen is not a formal adjuvant standard."@en ;
  schema:url <https://onco.cc/trials/apact/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01964430>, <https://doi.org/10.1200/JCO.22.01134> ;
  onco:status "negative" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/>, <https://onco.cc/cancers/resectable-pdac/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-nab-paclitaxel/>, <https://onco.cc/drugs/nab-paclitaxel/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:companies <https://onco.cc/companies/bms/> ;
  onco:terms <https://onco.cc/terms/pancreatic-failed-programmes/> .